|
?:authorAffiliation
|
-
[\'Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.\', \'Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.\', \'Vir Biotechnology, San Francisco, CA 94158, USA.\', \'Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institut Pasteur and CNRS UMR 3569, Unité de Virologie Structurale, Paris, France.\', \'Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.\', \'Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.\', \'III Division of Infectious Diseases, Luigi Sacco Hospital, University of Milan, 20157 Milan, Italy.\', \'Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland. Electronic address: dcorti@vir.bio.\', \'Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland. Electronic address: mpizzuto@vir.bio.\', \'Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. Electronic address: dveesler@uw.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}